27 related articles for article (PubMed ID: 1839590)
1. ENDOGLIN is dispensable for vasculogenesis, but required for vascular endothelial growth factor-induced angiogenesis.
Liu Z; Lebrin F; Maring JA; van den Driesche S; van der Brink S; van Dinther M; Thorikay M; Martin S; Kobayashi K; Hawinkels LJ; van Meeteren LA; Pardali E; Korving J; Letarte M; Arthur HM; Theuer C; Goumans MJ; Mummery C; ten Dijke P
PLoS One; 2014; 9(1):e86273. PubMed ID: 24489709
[TBL] [Abstract][Full Text] [Related]
2. Bisphosphonates act on rat bone resorption through the mediation of osteoblasts.
Sahni M; Guenther HL; Fleisch H; Collin P; Martin TJ
J Clin Invest; 1993 May; 91(5):2004-11. PubMed ID: 8486770
[TBL] [Abstract][Full Text] [Related]
3. New bisphosphonates in osteoporosis.
Fleisch H
Osteoporos Int; 1993; 3 Suppl 2():S15-22. PubMed ID: 8481594
[TBL] [Abstract][Full Text] [Related]
4. Osteoclast development in the coculture system of periostless metatarsal bones and hemopoietic cells studied by in situ hybridization with a probe for Y chromosomes.
Hagenaars CE; Kawilarang-de Haas EW; Hazekamp J; Wiegant J; Nijweide PJ
Calcif Tissue Int; 1994 Feb; 54(2):170-4. PubMed ID: 8012873
[TBL] [Abstract][Full Text] [Related]
5. Uninterrupted oral bisphosphonate (pamidronate) therapy of patients with osteoporosis is not associated with chronic stimulation of parathyroid hormone secretion.
Landman JO; Papapoulos SE
Osteoporos Int; 1995 Mar; 5(2):93-6. PubMed ID: 7599454
[TBL] [Abstract][Full Text] [Related]
6. A new model for the regulation of bone resorption, with particular reference to the effects of bisphosphonates.
Parfitt AM; Mundy GR; Roodman GD; Hughes DE; Boyce BF
J Bone Miner Res; 1996 Feb; 11(2):150-9. PubMed ID: 8822338
[No Abstract] [Full Text] [Related]
7. In vitro and ex vivo evidence that estrogens suppress increased bone resorption induced by ovariectomy or PTH stimulation through an effect on osteoclastogenesis.
Most W; Schot L; Ederveen A; van der Wee-Pals L; Papapoulos S; Löwik C
J Bone Miner Res; 1995 Oct; 10(10):1523-30. PubMed ID: 8686508
[TBL] [Abstract][Full Text] [Related]
8. Disodium 1-hydroxy-3-(1-pyrrolidinyl)-propylidene-1,1-bisphosphonate (EB-1053) is a potent inhibitor of bone resorption in vitro and in vivo.
van der Pluijm G; Binderup L; Bramm E; van der Wee-Pals L; De Groot H; Binderup E; Löwik C; Papapoulos S
J Bone Miner Res; 1992 Aug; 7(8):981-6. PubMed ID: 1442212
[TBL] [Abstract][Full Text] [Related]
9. Leukemia inhibitory factor inhibits osteoclastic resorption, growth, mineralization, and alkaline phosphatase activity in fetal mouse metacarpal bones in culture.
Van Beek E; Van der Wee-Pals L; van de Ruit M; Nijweide P; Papapoulos S; Löwik C
J Bone Miner Res; 1993 Feb; 8(2):191-8. PubMed ID: 8442437
[TBL] [Abstract][Full Text] [Related]
10. Effects of continuous and intermittent administration and inhibition of resorption on the anabolic response of bone to parathyroid hormone.
Hock JM; Gera I
J Bone Miner Res; 1992 Jan; 7(1):65-72. PubMed ID: 1532281
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of the inhibitory action of APD on the transformation of osteoclast precursors into resorbing cells after dimethylation of the amino group.
Boonekamp PM; Löwik CW; van der Wee-Pals LJ; van Wijk-van Lennep ML; Bijvoet OL
Bone Miner; 1987 Feb; 2(1):29-42. PubMed ID: 3504722
[TBL] [Abstract][Full Text] [Related]
12. Modulation of PTH-stimulated osteoclastic resorption by bisphosphonates in fetal mouse bone explants.
van der Pluijm G; Löwik CW; de Groot H; Alblas MJ; van der Wee-Pals LJ; Bijvoet OL; Papapoulos SE
J Bone Miner Res; 1991 Nov; 6(11):1203-10. PubMed ID: 1839590
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of action of bisphosphonates.
Reszka AA; Rodan GA
Curr Osteoporos Rep; 2003 Sep; 1(2):45-52. PubMed ID: 16036064
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
